Selecting the Optimal Design for Drug Discontinuation Trials in a Setting of Advanced, Life-Limiting Illness

Eric Geijteman, Henning Tiemeier, Teun Gelder

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1724-1725
Number of pages2
JournalJAMA Internal Medicine
Volume175
Issue number10
Publication statusPublished - 2015

Research programs

  • EMC MM-04-39-05
  • EMC NIHES-02-65-01
  • EMC NIHES-04-55-01
  • EMC OR-01-34-01

Cite this